1. The importance of impurity analysis in pharmaceutical products: an integrated approach
2. ICH Harmonised Tripartite , Impurities in new drug productsQ3B (R2) , current step 4, 2006
3. F.Simon , For the World Allergy Organization , World Allergy Organization survey on global availability essentials for the assessment and management of anaphylaxis by allergy\immunology specialists in health care settings , 2010 , vol. 104 , pp. 405–412
4. Epidemiology of allergic conjunctivitis